SMI closes higher as Galderma leads with 1.9 percent
Published on 10/12/2026 at 22:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- SMI closed on October 12, 2026 at 13,878 points, up 90 points or 0.7 percent.
- Brent crude traded near USD 103.70, down 1 percent, as supply concerns eased.
- Galderma led SMI gainers with a 1.9 percent rise.
- Givaudan reports nine-month sales on October 13, 2026.
The SMI closed on October 12, 2026 at 13,878 points, up 90 points or 0.7 percent. Easing geopolitical tensions supported Swiss stocks, while Brent crude traded near USD 103.70, down 1 percent, finanzen.ch and Saxo reported.
Galderma led the SMI with a 1.9 percent gain. Sandoz and Givaudan also ranked among the strongest performers, while the index extended its advance from midday trading.
Why did the SMI rise on October 12?
The SMI stayed in positive territory after opening at 13,847 points. The index moved between 13,817 and 13,896 points before settling higher, finanzen.ch reported.
Market sentiment improved as geopolitical tensions eased. Oil prices also retreated from an early spike above USD 105.50 after supply expectations offset renewed Middle East risks, finanzen.ch and Saxo said.
Galderma and Sandoz lead SMI movers
- Galderma up 1.9 percent
- Sandoz up 1.9 percent
- Givaudan up 1.4 percent
- VAT Group down 1.1 percent
- Lindt and Spruengli down 0.8 percent
- Swisscom down 0.5 percent, finanzen.ch reported
The SMI remained 0.7 percent higher for 2026. Its 2026 high stood at 14,670 points, leaving the index 792 points below that level, according to finanzen.ch.
What comes next for the SMI
Givaudan is scheduled to publish nine-month sales on October 13, 2026. Sulzer is due to release third-quarter order intake, while Swiss Re is scheduled to attend the Baden-Baden conference, cash.ch reported.
